Leading Virologist Dr. Clive Patience Appointed To Help Guide The Development Pf Sernova Corp.'s Proposed Diabetes Product

KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- December 04, 2006 -- Sernova Corp. ("Sernova") (TSX VENTURE: SVA) is pleased to announce that Dr. Clive Patience Ph.D. has joined its Scientific Advisory Board ("SAB") to assist the company with its diabetes product development.
MORE ON THIS TOPIC